March 27 (Bloomberg) -- Biogen Idec, the maker of multiple sclerosis drugs Avonex and Tysabri, won U.S. approvalfor its first pill for the disease, Tecfidera. Adam Johnson reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
How Apple Conquered China Market: Bloomberg West (01/30)
Jan. 30 -- Full episode of "Bloomberg West." Guests: GGV Capital's Hans Tung, Strategic Analytics' Neil Mawston, Evercore ISI's Ken Sena, CKE Restaurants CEO Andrew Puzder, Boost VC CEO Adam Draper and Zebra Technologies' Jill Stelfox.
Should Amazon Spin Off Its Growing Cloud Business?
TripAdvisor's Top Pick: Chicago's Langham Hotel
Dan Marino: Roger Goodell Has Done a Really Good Job
Please upgrade your Browser
Your browser is out-of-date. Please download one of these excellent browsers: